All In Biotech

Drug Trial Radar · NCT00607074

Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh

Effects of Anti-Giardia and Antihelmintic Treatment on Infant Nutritional and Biochemical Status and Intestinal Permeability in Rural Bangladesh

Last checked: Nov 20, 2026Latest source record: Feb 5, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 410 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

410

Actual

Start

Jun 2003

Primary completion

Apr 2004

Study completion Dec 2006

Sponsor

Lead sponsor
University of CambridgeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 5, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
Who can join
All sexes, from 3 months, up to 15 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This longitudinal study aimed to assess whether regular anti-Giardia and antihelmintic treatment improved growth and small intestinal mucosal function of rural Bangladeshi infants.

Conditions

  • Giardiasis

Interventions

  • Anti-Giardia and antihelmintic treatment (secnidazole or albendazole)Drug

    Every 4 weeks: Secnidazole (70mg/ml suspension, 0.5ml per kg of body weight) or a placebo was administered Every 12 weeks: Albendazole (syrup, 200mg)

  • Anti-Giardia treatment only (secnidazole or albendazole)Drug

    Every 4 weeks: Secnidazole (70mg/ml suspension, 0.5ml per kg of body weight) Every 12 weeks: placebo of Albendazole

  • Control group (placebo)Drug

    Every 4 weeks: Secnidazole placebo Every 12 weeks: Albendazole placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. nutritional statusTime frame: 9 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Institute of Preventive and Social Medicine

    Mohakhali, Dhaka Division, Bangladesh

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.